Adjunctive pregabalin therapy in mentally retarded, developmentally delayed patients with epilepsy

Epilepsy and Behavior

Volumn 13, Issue 3, 2008, Pages 554-556

  Modur, Pradeep N ^a   Milteer, Warren E ^b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b Hazelwood Center   (United States)

Author keywords

Antiepileptic drugs; Developmental delay; Epilepsy; Lennox Gastaut syndrome; Mental retardation; Myoclonus; Pregabalin; Seizure

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ABSENCE; ADULT; ARTICLE; CLINICAL ARTICLE; DEVELOPMENTAL DISORDER; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG USE; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; FOOT EDEMA; GRAND MAL SEIZURE; HUMAN; MAINTENANCE THERAPY; MALE; MENTAL DEFICIENCY; MYOCLONUS; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEDATION; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; TREATMENT DURATION; VAGUS NERVE STIMULATION; WEIGHT GAIN;

ADULT; ANTICONVULSANTS; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; MENTAL RETARDATION; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 50849091578     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2008.05.003     Document Type: Article

References (19)

1. Taylor C.P., Angelotti T., and Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73 (2007) 137-150
2. Ben-Menachem E. Pregabalin pharmacology and its relevance to clinical practice. Epilepsia 45 Suppl. 6 (2004) 13-18
3. French J.A., Kugler A.R., Robbins J.L., Knapp L.E., and Garofalo E.A. Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures. Neurology 60 (2003) 1631-1637
4. Arroyo S., Anhut H., Kugler A.R., et al. Pregabalin add-on treatment: a randomized, double-blind, placebo-controlled, dose-response study in adults with partial seizures. Epilepsia 45 (2004) 20-27
5. Beydoun A., Uthman B.M., Kugler A.R., Greiner M.J., Knapp L.E., and Garofalo E.A. Safety and efficacy of two pregabalin regimens for add-on treatment of partial epilepsy. Neurology 64 (2005) 475-480
6. Elger C.E., Brodie M.J., Anhut H., Lee C.M., and Barrett J.A. Pregabalin add-on treatment in patients with partial seizures: a novel evaluation of flexible-dose and fixed-dose treatment in a double-blind, placebo-controlled study. Epilepsia 46 (2005) 1926-1936
7. Arain A., Shihabuddin B., Niaz F., et al. Epilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting. Epilepsia 47 (2006) 2052-2057
8. McGrother C.W., Bhaumik S., Thorp C.F., et al. Epilepsy in adults with intellectual disabilities: prevalence, associations and service implications. Seizure 15 (2006) 376-386
9. Steffenburg U., Hedstrom A., Lindroth A., Wiklund L.M., Hagberg G., and Kyllerman M. Intractable epilepsy in a population-based series of mentally retarded children. Epilepsia 39 (1998) 767-775
10. Rutecki P.A., and Gidal B.E. Antiepileptic drug treatment in the developmentally disabled: treatment considerations with the newer antiepileptic drugs. Epilepsy Behav 3 (2002) 24-31
11. Commission. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the commission on classification and terminology of the International League Against Epilepsy. Epilepsia 1981;22:489-501.
12. Commission. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on classification and terminology of the International League Against Epilepsy. Epilepsia 1989;30:389-399.
13. Carreno M., Maestro I., Molins A., et al. Pregabalin as add-on therapy for refractory partial seizures in every day clinical practice. Seizure 16 (2007) 709-712
14. Noachtar S.M., Andermann E.M.D.P.F., Meyvisch P.M., et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70 (2008) 607-616
15. Huppertz H.J., Feuerstein T.J., and Schulze-Bonhage A. Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin. Epilepsia 42 (2001) 790-792
16. Knake S., Klein K.M., Hattemer K., et al. Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain. Epilepsy Behav 11 (2007) 471-473
17. Perucca E., Gram L., Avanzini G., and Dulac O. Antiepileptic drugs as a cause of worsening seizures. Epilepsia 39 (1998) 5-17
18. Genton P. When antiepileptic drugs aggravate epilepsy. Brain Dev 22 (2000) 75-80
19. Asconape J., Diedrich A., and DellaBadia J. Myoclonus associated with the use of gabapentin. Epilepsia 41 (2000) 479-481